| LINE ITEM (USD / %) | FY 2025
FILED 2025-12-31 | FY 2024
FILED 2024-12-31 | FY 2023
FILED 2023-12-31 |
|---|---|---|---|
| Revenue (Total Sales) | $9.73B | $9.19B | $8.73B |
| YoY Revenue Growth % | +5.8% | +5.2% | — |
| Gross Profit | — | — | — |
| Gross Margin % | — | — | — |
| Research & Development (R&D) | — | — | — |
| Operating Income (EBIT) | $5.94B | $5.29B | $4.90B |
| Operating Margin % | 61.1% | 57.5% | 56.1% |
| Net Income (GAAP) | $0 | $0 | $3.93B |
| EBITDA (Normalized) | $7.39B | $6.13B | $5.21B |
| Diluted EPS ($/sh) | — | — | — |
| Operating Cash Flow (OCF) | $5.91B | $5.95B | $5.40B |
| Capital Expenditures (CapEx) | $1.81B | $1.06B | $393.0M |
| Free Cash Flow (FCF) | $4.10B | $4.89B | $5.00B |
| FCF Margin % | 42.2% | 53.2% | 57.3% |
| Return on Invested Capital (ROIC %) | 18.6% | 18.1% | 19.2% |
| Cash & Short-Term Equivalents | $2.14B | $1.52B | — |
| Total Debt (Short + Long Term) | $12.81B | $10.58B | $7.81B |
| Total Stockholders' Equity | $14.53B | $14.01B | $16.03B |